You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
The economic benefit of the oral formulation of nimodipine over the intravenous formulation
- In: Hospital Pharmacy Posters
- At: Hyderabad (India) (2011)
- Type: Poster
- Poster code: HPS-P-50
- By: HADAD, Salim (Rambam Health Care Campus, Haifa, Israel)
- Co-author(s): Hadad, Salim (2. Division of Pharmacy. Rambam Health Care Campus, Haifa, Israel)
Nassar, Laila (Pharmacy service. Rambam Health Care Campus, Haifa, Israel)
Levi, Leon (Neurosurgery, Rambam Health Care Campus, Haifa, Israel) - Abstract:
Introduction: Nimodipine is nifedipine analogue. It differs from other Calcium channel blockers by its ability to dilate cerebral vessels to a greater extent than cardiovascular vessels. Its only FDA approved indication is subarachnoid hemorrhage, from ruptured intracranial berry aneurysm.
..
The drug is available as both, intravenous and oral The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026